perimenopause 发表于 2025-3-23 13:20:43

http://reply.papertrans.cn/2/126/12523/12523-11.png

Coterminous 发表于 2025-3-23 15:14:16

Submitted on: 04 October 2016.
Revised on: 22 November 2016.
Accepted on: 17 January 2017.

___________________INFLAMMOPHARMACOLOGY---SPRINGER BASEL AG

lethargy 发表于 2025-3-23 19:12:21

http://reply.papertrans.cn/2/126/12523/12523-13.png

Monocle 发表于 2025-3-23 23:15:40

http://reply.papertrans.cn/2/126/12523/12523-14.png

cunning 发表于 2025-3-24 02:37:45

http://reply.papertrans.cn/2/126/12523/12523-15.png

frenzy 发表于 2025-3-24 07:21:29

Submitted on: 16 April 2024.
Revised on: 03 August 2024.
Accepted on: 11 September 2024.

___________________INFLAMMOPHARMACOLOGY---SPRINGER BASEL AG

circuit 发表于 2025-3-24 13:57:10

Submitted on: 09 April 2012.
Revised on: 03 May 2012.
Accepted on: 14 May 2012.

___________________INFLAMMOPHARMACOLOGY---SPRINGER BASEL AG

钳子 发表于 2025-3-24 16:08:39

Submitted on: 26 January 2009.
Revised on: 20 May 2009.
Accepted on: 03 July 2009.

___________________INFLAMMOPHARMACOLOGY---SPRINGER BASEL AG

刀锋 发表于 2025-3-24 22:06:18

http://reply.papertrans.cn/2/126/12523/12523-19.png

引导 发表于 2025-3-25 01:35:14

http://reply.papertrans.cn/2/126/12523/12523-20.png
页: 1 [2] 3 4
查看完整版本: SCIE期刊INFLAMMOPHARMACOLOGY 2024/2025影响因子:4.674 (INFLAMMOPHARMACOLOGY) (0925-4692). (IMMUNOLOGY)(免疫学)Science Citation In